EDGE Insider Trading Activity and SEC Form 4 Filings
EDGE insider trading summary
No open-market insider purchases or sales of Edge Therapeutics, Inc. (EDGE) have been reported on SEC Form 4 in the past 12 months.
Latest EDGE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 22, 2018 | R. Loch Macdonald | Chief Scientific Officer | Sell | $41K (2,500 @ $16.41) |
| Mar 21, 2018 | R. Loch Macdonald | Chief Scientific Officer | Sell | $41K (2,500 @ $16.52) |
| Mar 20, 2018 | R. Loch Macdonald | Chief Scientific Officer | Sell | $82K (5,000 @ $16.47) |
| Mar 19, 2018 | R. Loch Macdonald | Chief Scientific Officer | Sell | $42K (2,500 @ $16.66) |
| Mar 2, 2018 | Brian A Leuthner | President and CEO | Sell | $38K (2,500 @ $15.08) |
| Mar 1, 2018 | Brian A Leuthner | President and CEO | Sell | $37K (2,500 @ $14.81) |
| Feb 23, 2018 | Brian A Leuthner | President and CEO | Sell | $38K (2,500 @ $15.37) |
| Feb 22, 2018 | Brian A Leuthner | President and CEO | Sell | $39K (2,500 @ $15.47) |
| Feb 22, 2018 | R. Loch Macdonald | Chief Scientific Officer | Sell | $36K (2,500 @ $14.49) |
| Feb 21, 2018 | R. Loch Macdonald | Chief Scientific Officer | Sell | $69K (5,000 @ $13.82) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.